|
1
|
Tang C, Zhou K, Wu D and Zhu H:
Nanoparticles as a novel platform for cardiovascular disease
diagnosis and therapy. Int J Nanomedicine. 19:8831–8846. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ayob R, Vally M, Khan R and Orchard A:
Disparities in patients' understanding of cardiovascular disease
management. Cardiovasc J Afr. 34:1–7. 2024.PubMed/NCBI
|
|
3
|
(WHO) WHO, . Cardiovascular diseases
(CVDs) 2023. 2017.
|
|
4
|
Frumuzachi O, Babotă M, Tanase C and Mocan
A: A systematic review of randomized controlled trials on the
health effects of chocolate enriched/fortified/supplemented with
functional components. Food Funct. 15:6883–6899. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding D, Lawson KD, Kolbe-Alexander TL,
Finkelstein EA, Katzmarzyk PT, van Mechelen W and Pratt M; Lancet
Physical Activity Series 2 Executive Committee, : The economic
burden of physical inactivity: A global analysis of major
non-communicable diseases. Lancet. 388:1311–1324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kazi DS, Katznelson E, Liu CL, Al-Roub NM,
Chaudhary RS, Young DE, McNichol M, Mickley LJ, Kramer DB, Cascio
WE, et al: Climate change and cardiovascular health: A systematic
review. JAMA Cardiol. 9:748–757. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hundley WG: Fifty years of cardiovascular
magnetic resonance: Continuing evolution toward the ‘One-Stop Shop’
for cardiovascular diagnosis. Circulation. 149:1859–1861. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng X, Zhou L, Zeng Q, Zhu H and Luo J:
High serum copper as a risk factor of all-cause and cause-specific
mortality among US adults, NHANES 2011–2014. Front Cardiovasc Med.
11:13409682024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mazur T, Malik M and Bieńko DC: The impact
of chelating compounds on Cu2+,
Fe2+/3+, and Zn2+ ions in
Alzheimer's disease treatment. J Inorg Biochem. 257:1126012024.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Einhorn V, Haase H and Maares M:
Interaction and competition for intestinal absorption by zinc,
iron, copper, and manganese at the intestinal mucus layer. J Trace
Elem Med Biol. 84:1274592024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue Q, Kang R, Klionsky DJ, Tang D, Liu J
and Chen X: Copper metabolism in cell death and autophagy.
Autophagy. 19:2175–2195. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsymbal SA, Refeld AG and Kuchur OA: The
p53 tumor suppressor and copper metabolism: An unrevealed but
important link. Mol Biol (Mosk). 56:1057–1071. 2022.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J, Jiang Y, Shi H, Peng Y, Fan X and
Li C: The molecular mechanisms of copper metabolism and its roles
in human diseases. Pflugers Arch. 472:1415–1429. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ruiz LM, Libedinsky A and Elorza AA: Role
of copper on mitochondrial function and metabolism. Front Mol
Biosci. 8:7112272021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kerkadi A, Raïq H, Prince MS, Bader L,
Soltani A and Agouni A: A cross-sectional analysis of zinc and
copper levels and their relationship to cardiovascular disease risk
markers in Qatar biobank participants. Front Cardiovasc Med.
10:13055882024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Weichenthal S, Kwong JC, Burnett
RT, Hatzopoulou M, Jerrett M, van Donkelaar A, Bai L, Martin RV,
Copes R, et al: A Population-based cohort study of respiratory
disease and long-term exposure to Iron and copper in fine
particulate air pollution and their combined impact on reactive
oxygen species generation in human lungs. Environ Sci Technol.
55:3807–3818. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rashidmayvan M, Mansoori A, Aghasizadeh M,
Dianati M, Barati S, Sahranavard T, Darroudi S, Ahari RK, Esmaily
H, Ferns G, et al: Prediction of cardiovascular disease risk by
serum zinc and copper concentrations and anthropometric
measurements. J Trace Elem Med Biol. 83:1273852024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lan L, Feng Z, Liu X and Zhang B: The
roles of essential trace elements in T cell biology. J Cell Mol
Med. 28:e183902024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dyla M, Kjærgaard M, Poulsen H and Nissen
P: Structure and mechanism of P-type ATPase Ion pumps. Annu Rev
Biochem. 89:583–603. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu C, Liu Y, Zhang Y and Gao L: The role
of a cuproptosis-related prognostic signature in colon cancer tumor
microenvironment and immune responses. Front Genet. 13:9281052022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shan J, Geng R, Zhang Y, Wei J, Liu J and
Bai J: Identification of cuproptosis-related subtypes,
establishment of a prognostic model and tumor immune landscape in
endometrial carcinoma. Comput Biol Med. 149:1059882022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Wang D, Wu C, Wang B, He S, Wang
H, Liang G and Zhang Y: MMP 9-instructed assembly of bFGF
nanofibers in ischemic myocardium to promote heart repair.
Theranostics. 12:7237–7249. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Xu X, Zhang T, Xu L, Tao H, Liu Y,
Zhang Y and Meng X: Fatty acid metabolism disorders and potential
therapeutic traditional Chinese medicines in cardiovascular
diseases. Phytother Res. 37:4976–4998. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazaheri-Tehrani S, Haghighatpanah MA,
Abhari AP, Fakhrolmobasheri M, Shekarian A and Kieliszek M: Dynamic
changes of serum trace elements following cardiac surgery: A
systematic review and meta-analysis. J Trace Elem Med Biol.
81:1273312023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teschke R and Eickhoff A: Wilson disease:
Copper-mediated Cuproptosis, Iron-related Ferroptosis, and clinical
highlights, with comprehensive and critical analysis update. Int J
Mol Sci. 25:47532024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Garrick MD, Garrick LM, Zhao L
and Collins JF: Divalentmetal transporter 1 (Dmt1) mediates copper
transport in the duodenum of iron-deficient rats and when
overexpressed in iron-deprived HEK-293 cells. J Nutr.
143:1927–1933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui X and Wang Y, Liu H, Shi M, Wang J and
Wang Y: The molecular mechanisms of defective copper metabolism in
diabetic cardiomyopathy. Oxid Med Cell Longev. 2022:54183762022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nývltová E, Dietz JV, Seravalli J,
Khalimonchuk O and Barrientos A: Coordination of metal center
biogenesis in human cytochrome c oxidase. Nat Commun. 13:36152022.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pagnotta S, Tramutola A, Barone E, Di
Domenico F, Pittalà V, Salerno L, Folgiero V, Caforio M, Locatelli
F, Petrini S, et al: CAPE and its synthetic derivative VP961
restore BACH1/NRF2 axis in Down syndrome. Free Radic Biol Med.
183:1–13. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matson Dzebo M, Ariöz C and
Wittung-Stafshede P: Extended functional repertoire for human
copper chaperones. Biomol Concepts. 7:29–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tadini-Buoninsegni F and Smeazzetto S:
Mechanisms of charge transfer in human copper ATPases ATP7A and
ATP7B. IUBMB Life. 69:218–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pierson H, Muchenditsi A, Kim BE, Ralle M,
Zachos N, Huster D and Lutsenko S: The function of ATPase copper
transporter ATP7B in intestine. Gastroenterology. 154:168–180.e5.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ovchinnikova EV, Garbuz MM, Ovchinnikova
AA and Kumeiko VV: Epidemiology of Wilson's disease and pathogenic
variants of the ATP7B gene leading to diversified protein
disfunctions. Int J Mol Sci. 25:24022024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang L, Yang P, Lip GYH and Ren J: Copper
homeostasis and cuproptosis in cardiovascular disease therapeutics.
Trends Pharmacol Sci. 44:573–585. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Ling J, Hu Q, Fang C, Mei K, Wu Y,
Huang J, Ling Q, Chen Y, Yu P, et al: Association of serum copper
(Cu) with cardiovascular mortality and all-cause mortality in a
general population: A prospective cohort study. BMC Public Health.
23:21382023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dascalu AM, Anghelache A, Stana D, Costea
AC, Nicolae VA, Tanasescu D, Costea DO, Tribus LC, Zgura A, Serban
D, et al: Serum levels of copper and zinc in diabetic retinopathy:
Potential new therapeutic targets (Review). Exp Ther Med.
23:3242022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lutsenko S, Roy S and Tsvetkov P:
Mammalian copper homeostasis: Physiologic roles and molecular
mechanisms. Physiol Rev. Aug 22–2024.doi:
10.1152/physrev.00011.2024 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Forman HJ and Zhang H: Targeting oxidative
stress in disease: Promise and limitations of antioxidant therapy.
Nat Rev Drug Discov. 20:689–709. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Husain N and Mahmood R: Copper(II)
generates ROS and RNS, impairs antioxidant system and damages
membrane and DNA in human blood cells. Environ Sci Pollut Res Int.
26:20654–20668. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jomova K, Alomar SY, Alwasel SH,
Nepovimova E, Kuca K and Valko M: Several lines of antioxidant
defense against oxidative stress: Antioxidant enzymes,
nanomaterials with multiple enzyme-mimicking activities, and
low-molecular-weight antioxidants. Arch Toxicol. 98:1323–1367.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun D, Sun X, Zhang X, Wu J, Shi X, Sun J,
Luo C, He Z and Zhang S: Emerging chemodynamic nanotherapeutics for
cancer treatment. Adv Healthc Mater. 16:e24008092024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang R, Zhu L, Huang Y, Chen J and Tang
Q: Mitochondria: Fundamental characteristics, challenges, and
impact on aging. Biogerontology. Aug 28–2024.doi:
10.1007/s10522-024-10132-8 (Epub ahead of print). View Article : Google Scholar
|
|
43
|
Zhu SY, Liu J and Yu C: Research progress
on mitochondrial copper homeostasis imbalance and fibrosis
diseases. Sheng Li Xue Bao. 76:597–604. 2024.(In Chinese).
PubMed/NCBI
|
|
44
|
Bomer N, Pavez-Giani MG, Grote Beverborg
N, Cleland JGF, van Veldhuisen DJ and van der Meer P: Micronutrient
deficiencies in heart failure: Mitochondrial dysfunction as a
common pathophysiological mechanism? J Intern Med. 291:713–731.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Swaminathan AB and Gohil VM: The role of
COA6 in the mitochondrial copper delivery pathway to cytochrome c
oxidase. Biomolecules. 12:1252022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Qian L, Zhu Y, Deng C, Liang Z, Chen J,
Chen Y, Wang X, Liu Y, Tian Y and Yang Y: Peroxisome
proliferator-activated receptor gamma coactivator-1 (PGC-1) family
in physiological and pathophysiological process and diseases.
Signal Transduct Target Ther. 9:502024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xiao Y, Wang T, Song X, Yang D, Chu Q and
Kang YJ: Copper promotion of myocardial regeneration. Exp Biol Med
(Maywood). 245:911–921. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wan JJ, Yi J, Wang FY, Zhang C and Dai AG:
Expression and regulation of HIF-1a in hypoxic pulmonary
hypertension: Focus on pathological mechanism and Pharmacological
Treatment. Int J Med Sci. 21:45–60. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li D, Li D, Wang Z, Li J, Shahzad KA, Wang
Y and Tan F: Signaling pathways activated and regulated by stem
cell-derived exosome therapy. Cell Biosci. 14:1052024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Himoto T, Fujita K, Nomura T, Tani J,
Miyoshi H, Morishita A, Yoneyama H, Kubota S, Haba R, Suzuki Y and
Masaki T: Roles of copper in Hepatocarcinogenesis via the
activation of Hypoxia-inducible factor-1α. Biol Trace Elem Res.
174:58–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Martínez-González J, Varona S, Cañes L,
Galán M, Briones AM, Cachofeiro V and Rodríguez C: Emerging roles
of Lysyl oxidases in the cardiovascular system: New concepts and
therapeutic challenges. Biomolecules. 9:6102019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ashino T, Kohno T, Sudhahar V, Ash D,
Ushio-Fukai M and Fukai T: Copper transporter ATP7A interacts with
IQGAP1, a Rac1 binding scaffolding protein: Role in PDGF-induced
VSMC migration and vascular remodeling. Am J Physiol Cell Physiol.
315:C850–C862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Viskin S, Chorin E, Schwartz AL, Kukla P
and Rosso R: Arrhythmogenic effects of cardiac memory. Circulation.
146:1170–1181. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hsiao CD, Wu HH, Malhotra N, Liu YC, Wu
YH, Lin YN, Saputra F, Santoso F and Chen KH: Expression and
purification of recombinant GHK Tripeptides are able to protect
against acute cardiotoxicity from exposure to waterborne-copper in
Zebrafish. Biomolecules. 10:12022020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shen H and Nugegoda D: Real-time automated
behavioural monitoring of mussels during contaminant exposures
using an improved microcontroller-based device. Sci Total Environ.
806:1505672022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bobbio E, Forsgard N, Oldfors A,
Szamlewski P, Bollano E, Andersson B, Lingbrant M, Bergh N, Karason
K and Polte CL: Cardiac arrest in Wilson's disease after curative
liver transplantation: A life-threatening complication of
myocardial copper excess? ESC Heart Fail. 6:228–231. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bagheri B, Akbari N, Tabiban S, Habibi V
and Mokhberi V: Serum level of copper in patients with coronary
artery disease. Niger Med J. 56:39–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kciuk M, Gielecińska A, Kałuzińska-Kołat
Ż, Yahya EB and Kontek R: Ferroptosis and cuproptosis:
Metal-dependent cell death pathways activated in response to
classical chemotherapy-Significance for cancer treatment? Biochim
Biophys Acta Rev Cancer. 1879:1891242024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen Z, Li YY and Liu X: Copper
homeostasis and copper-induced cell death: Novel targeting for
intervention in the pathogenesis of vascular aging. Biomed
Pharmacother. 169:1158392023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Begum S, Sultana I, Faysal MR, Alam S,
Tasnim J, Akter T, Hossain MS, Banu M, Jenea AT, Hasan M, et al:
Study of changes in serum copper level in patients with acute
myocardial infarction. Mymensingh Med J. 32:39–43. 2023.PubMed/NCBI
|
|
61
|
El-Hajjar L, Hindieh J, Andraos R,
El-Sabban M and Daher J: Myeloperoxidase-oxidized LDL activates
human aortic endothelial cells through the LOX-1 scavenger
receptor. Int J Mol Sci. 23:28372022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gao L and Zhang A: Copper-instigated
modulatory cell mortality mechanisms and progress in oncological
treatment investigations. Front Immunol. 14:12360632023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
He Y, Huang W, Zhang C, Chen L, Xu R, Li
N, Wang F, Han L, Yang M and Zhang D: Energy metabolism disorders
and potential therapeutic drugs in heart failure. Acta Pharm Sin B.
11:1098–1116. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xing L, Liu Y, Wang J, Tian P and Liu P:
High-density lipoprotein and heart failure. Rev Cardiovasc Med.
24:3212023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yuan HJ, Xue YT and Liu Y: Cuproptosis,
the novel therapeutic mechanism for heart failure: A narrative
review. Cardiovasc Diagn Ther. 12:681–692. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Huang L, Shen R, Huang L, Yu J and Rong H:
Association between serum copper and heart failure: A
meta-analysis. Asia Pac J Clin Nutr. 28:761–769. 2019.PubMed/NCBI
|
|
67
|
Zhang S, Liu H, Amarsingh GV, Cheung CCH,
Wu D, Narayanan U, Zhang L and Cooper GJS: Restoration of
myocellular copper-trafficking proteins and mitochondrial copper
enzymes repairs cardiac function in rats with diabetes-evoked heart
failure. Metallomics. 12:259–272. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Liu Y and Miao J: An emerging role of
defective copper metabolism in heart disease. Nutrients.
4:7002019.
|
|
69
|
Qi W, Liu L, Zeng Q, Zhou Z, Chen D, He B,
Gong S, Gao L, Wang X, Xiong J, et al: Contribution of cuproptosis
and Cu metabolism-associated genes to chronic obstructive pulmonary
disease. J Cell Mol Med. 27:4034–4044. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bost M, Houdart S, Oberli M, Kalonji E,
Huneau JF and Margaritis I: Dietary copper and healthy: Current
evidence and unresolved issues. J Trace Elem Med Biol. 35:107–115.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gelpi Acevedo LM, Salinas AL, Polanco JS,
Nizami H, Marsh D, Patel M, Parikh K and Jain R and Jain R: A
narrative review of the pathophysiology and treatment of
hypertrophic cardiomyopathy. South Med J. 115:926–929. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Butzner M, Aronitz E, Cameron H, Tantakoun
K, Shreay S and Drudge C: An evidence review and gap analysis for
obstructive hypertrophic cardiomyopathy. BMC Cardiovasc Disord.
24:4162024. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Reid A, Miller C, Farrant JP, Polturi R,
Clark D, Ray S, Cooper G and Schmitt M: Copper chelation in
patients with hypertrophic cardiomyopathy. Open Heart.
9:e0018032022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Cinato M, Andersson L, Miljanovic A,
Laudette M, Kunduzova O, Borén J and Levin MC: Role of perilipins
in oxidative Stress-implications for cardiovascular disease.
Antioxidants (Basel). 13:2092024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ali SA, Bommaraju S, Patwa J, Khare P,
Rachamalla M, Niyogi S and Datusalia AK: Melatonin attenuates
extracellular matrix accumulation and cardiac injury manifested by
copper. Biol Trace Elem Res. 201:4456–4471. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Tsvetkov P, Coy S, Petrova B, Dreishpoon
M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R,
Spangler RD, et al: Copper induces cell death by targeting
lipoylated TCA cycle proteins. Science. 375:1254–1261. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Van Den Heuvel LJF, Peeters S, Meester
JAN, Coucke PJ and Loeys BL: An exploration of alternative
therapeutic targets for aortic disease in Marfan syndrome. Drug
Discov Today. 29:1040232024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Liu B, Yang H, Song YS, Sorenson CM and
Sheibani N: Thrombospondin-1 in vascular development, vascular
function, and vascular disease. Semin Cell Dev Biol. 155:32–44.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Tsui KH, Hsiao JH, Lin LT, Tsang YL, Shao
AN, Kuo CH, Chang R, Wen ZH and Li CJ: The Cross-communication of
Cuproptosis and regulated cell death in human pathophysiology. Int
J Biol Sci. 20:218–230. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li Y, Qi P, Song SY and Wang Y, Wang H,
Cao P, Liu Y and Wang Y: Elucidating cuproptosis in metabolic
dysfunction-associated steatotic liver disease. Biomed
Pharmacother. 174:1165852024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Rucklidge JJ, Eggleston MJF, Darling KA,
Stevens AJ, Kennedy MA and Frampton CM: Can we predict treatment
response in children with ADHD to a vitamin-mineral supplement? An
investigation into pre-treatment nutrient serum levels, MTHFR
status, clinical correlates and demographic variables. Prog
Neuropsychopharmacol Biol Psychiatry. 89:181–192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kunutsor SK, Dey RS and Laukkanen JA:
Circulating serum copper is associated with atherosclerotic
cardiovascular disease, but not venous thromboembolism: A
prospective cohort study. Pulse (Basel). 9:109–115. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhu C, Wang B, Xiao L, Guo Y, Zhou Y, Cao
L, Yang S and Chen W: Mean platelet volume mediated the
relationships between heavy metals exposure and atherosclerotic
cardiovascular disease risk: A community-based study. Eur J Prev
Cardiol. 27:830–839. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Alexanian I, Parissis J, Farmakis D,
Athanaselis S, Pappas L, Gavrielatos G, Mihas C, Paraskevaidis I,
Sideris A, Kremastinos D, et al: Clinical and echocardiographic
correlates of serum copper and zinc in acute and chronic heart
failure. Clin Res Cardiol. 103:938–949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Malek F, Jiresova E, Dohnalova A,
Koprivova H and Spacek R: Serum copper as a marker of inflammation
in prediction of short term outcome in high risk patients with
chronic heart failure. Int J Cardiol. 113:e51–e53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Nyström-Rosander C, Frisk P, Edvinsson M,
Hjelm E, Thelin S, Friman G and Ilbäck NG: Thoracic aortic aneurysm
patients with Chlamydophila pneumoniae infection showed a shift in
trace element levels in serum and diseased aortic tissue. J Trace
Elem Med Biol. 23:100–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Koksal C, Ercan M, Bozkurt AK,
Cortelekoglu T and Konukoglu D: Abdominal aortic aneurysm or aortic
occlusive disease: Role of trace element imbalance. Angiology.
58:191–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Qin Z, Konaniah ES, Neltner B, Nemenoff
RA, Hui DY and Weintraub NL: Participation of ATP7A in macrophage
mediated oxidation of LDL. J Lipid Res. 51:1471–1477. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ploplis VA, Cornelissen I, Sandoval-Cooper
MJ, Weeks L, Noria FA and Castellino FJ: Remodeling of the vessel
wall after copper-induced injury is highly attenuated in mice with
a total deficiency of plasminogen activator inhibitor-1. Am J
Pathol. 158:107–117. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Bini G, Santini G and Chelazzi G:
Pre-exposure to cadmium or zinc alters the heart rate response of
the crayfish Procambarus clarkii towards copper. Bull
Environ Contam Toxicol. 95:12–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Li Q, Liao J, Lei C, Shi J, Zhang H, Han
Q, Guo J, Hu L, Li Y, Pan J and Tang Z: Metabolomics analysis
reveals the effect of copper on autophagy in myocardia of pigs.
Ecotoxicol Environ Saf. 213:1120402021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li S, Zhao H, Wang Y, Shao Y, Wang B, Wang
Y and Xing M: Regulation of autophagy factors by oxidative stress
and cardiac enzymes imbalance during arsenic or/and copper induced
cardiotoxicity in Gallus gallus. Ecotoxicol Environ Saf.
148:125–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zheng L, Han P, Liu J, Li R, Yin W, Wang
T, Zhang W and Kang YJ: Role of copper in regression of cardiac
hypertrophy. Pharmacol Ther. 148:66–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Charkiewicz AE: Is copper still safe for
us? What do we know and what are the latest literature statements?
Curr Issues Mol Biol. 46:8441–8463. 2024.PubMed/NCBI
|
|
95
|
Milanković V, Tasić T, Leskovac A,
Petrović S, Mitić M, Lazarević-Pašti T, Novković M and Potkonjak N:
Metals on the Menu-analyzing the presence, importance, and
consequences. Foods. 13:18902024. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Klevay LM: Is the Western diet adequate in
copper? J Trace Elem Med Biol. 25:204–212. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Klevay LM: Lack of a recommended dietary
allowance for copper may be hazardous to your health. J Am Coll
Nutr. 17:322–326. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Saari JT: Copper deficiency and
cardiovascular disease: Role of peroxidation, glycation, and
nitration. Can J Physiol Pharmacol. 78:848–855. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yamane R, Tanaka M, Kikugawa N, Yasui H,
Takei K, Harada M and Kaneda S: Mesh-like vascular changes in
copper deficiency-induced rat cardiomyopathy. J Toxicol Pathol.
34:127–133. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Liu ZY, Liu ZY, Lin LC, Song K, Tu B,
Zhang Y, Yang JJ, Zhao JY and Tao H: Redox homeostasis in cardiac
fibrosis: Focus on metal ion metabolism. Redox Biol. 71:1031092024.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ramani PK and Parayil Sankaran B: Menkes
disease. 2023 Nov 14. StatPearls [Internet] Treasure Island (FL):
StatPearls Publishing; Jan. 2024
|
|
102
|
Parsanathan R: Copper's dual role:
Unravelling the link between copper homeostasis, cuproptosis, and
cardiovascular diseases. Hypertens Res. 47:1440–1442. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yang S, Li Y, Zhou L, Wang X, Liu L and Wu
M: Copper homeostasis and cuproptosis in atherosclerosis:
Metabolism, mechanisms and potential therapeutic strategies. Cell
Death Discov. 10:252024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Al-Bayati MA, Jamil DA and Al-Aubaidy HA:
Cardiovascular effects of copper deficiency on activity of
superoxide dismutase in diabetic nephropathy. N Am J Med Sci.
7:41–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang Z, Jin D, Zhou S, Dong N, Ji Y, An P,
Wang J, Luo Y and Luo J: Regulatory roles of copper metabolism and
cuproptosis in human cancers. Front Oncol. 13:11234202023.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Habas K and Shang L: Alterations in
intercellular adhesion molecule 1 (ICAM-1) and vascular cell
adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue
Cell. 54:139–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Chen L, Min J and Wang F: Copper
homeostasis and cuproptosis in health and disease. Signal Transduct
Target Ther. 7:3782022. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Jeney V, Itoh S, Wendt M, Gradek Q,
Ushio-Fukai M, Harrison DG and Fukai T: Role of antioxidant-1 in
extracellular superoxide dismutase function and expression. Circ
Res. 96:723–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Tural K, Ozden O, Bilgi Z, Kubat E,
Ermutlu CS, Merhan O, Findik Guvendi K and Kucuker SA: The
protective effect of betanin and copper on heart and lung in
end-organ ischemia reperfusion injury. Bratisl Lek Listy.
121:211–217. 2020.PubMed/NCBI
|
|
110
|
Srinivasan S and Avadhani NG: Cytochrome c
oxidase dysfunction in oxidative stress. Free Radic Biol Med.
53:1252–1263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Johnson WT and Newman SM Jr: Hearts in
adult offspring of copper-deficient dams exhibit decreased
cytochrome c oxidase activity, increased mitochondrial hydrogen
peroxide generation and enhanced formation of intracellular
residual bodies. J Nutr Biochem. 18:97–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Medeiros DM and Wildman RE: Newer findings
on a unified perspective of copper restriction and cardiomyopathy.
Proc Soc Exp Biol Med. 215:299–313. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhou Z, Johnson WT and Kang YJ: Regression
of copper-deficient heart hypertrophy: Reduction in the size of
hypertrophic cardiomyocytes. J Nutr Biochem. 20:621–628. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Gu J, Huang W, Duanmu Z, Zhuang R and Yang
X: Cuproptosis and copper deficiency in ischemic vascular injury
and repair. Apoptosis. 29:1007–1018. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Klevay LM: IHD from copper deficiency: A
unified theory. Nutr Res Rev. 29:172–179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Klevay LM and Viestenz KE: Abnormal
electrocardiograms in rats deficient in copper. Am J Physiol.
240:H185–H189. 1981.PubMed/NCBI
|
|
117
|
Viestenz KE and Klevay LM: A randomized
trial of copper therapy in rats with electrocardiographic
abnormalities due to copper deficiency. Am J Clin Nutr. 35:258–266.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Bevan R and Levy L: Biomonitoring for
workplace exposure to copper and its compounds is currently not
interpretable. Int J Hyg Environ Health. 258:1143582024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
WHO. World Health Organization, . Copper
in Drinking-Water. Background document for development of WHO
Guidelines for Drinking-water Quality. 2004.
|
|
120
|
Taylor AA, Tsuji JS, McArdle ME, Adams WJ
and Goodfellow WL Jr: Recommended reference values for risk
assessment of oral exposure to copper. Risk Anal. 43:211–218. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Toscano CM, Filetti FM, Almenara CCP,
Fioresi M and Vassallo DV: Copper exposure for 30 days at a daily
dose twice the recommended increases blood pressure and cardiac
contractility. Life Sci. 300:1205792022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Filetti FM, Schereider IRG, Wiggers GA,
Miguel M, Vassallo DV and Simões MR: Cardiovascular harmful effects
of recommended daily doses (13 µg/kg/day), tolerable upper intake
doses (0.14 mg/kg/day) and twice the tolerable doses (0.28
mg/kg/day) of copper. Cardiovasc Toxicol. 23:218–229. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Abbasi H, Khoshdooz S, Abbasi MM, Pasand M
and Eslamian G: Shining a light on trace elements: A systematic
review and Meta-analysis of serum concentrations in febrile
seizure. Biol Trace Elem Res. May 8–2024.doi:
10.1007/s12011-024-04221-5 (Epub ahead of print). View Article : Google Scholar
|
|
124
|
Gucký A and Hamuľaková S: Targeting
biometals in Alzheimer's disease with metal chelating agents
including coumarin derivatives. CNS Drugs. 38:507–532. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kannan S, Gillespie SW, Picking WL,
Picking WD, Lorson CL and Singh K: Inhibitors against DNA
polymerase I family of enzymes: Novel targets and opportunities.
Biology (Basel). 13:2042024.PubMed/NCBI
|
|
126
|
Yang D, Wang T, Liu J, Wang H and Kang YJ:
Reverse regulation of hepatic ceruloplasmin production in rat model
of myocardial ischemia. J Trace Elem Med Biol. 64:1266862021.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zou Y, Wu S, Xu X, Tan X, Yang S, Chen T,
Zhang J, Li S, Li W and Wang F: Cope with copper: From molecular
mechanisms of cuproptosis to copper-related kidney diseases. Int
Immunopharmacol. 133:1120752024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Gromadzka G, Grycan M and Przybyłkowski
AM: Monitoring of copper in wilson disease. Diagnostics (Basel).
13:18302023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wei H, Zhang WJ, McMillen TS, Leboeuf RC
and Frei B: Copper chelation by tetrathiomolybdate inhibits
vascular inflammation and atherosclerotic lesion development in
apolipoprotein E-deficient mice. Atherosclerosis. 223:306–313.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Ferrero ME: Neuron protection by EDTA may
explain the successful outcomes of toxic metal chelation therapy in
neurodegenerative diseases. Biomedicines. 10:24762022. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Fulgenzi A and Ferrero ME: EDTA chelation
therapy for the treatment of neurotoxicity. Int J Mol Sci.
20:10192019. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Litwin T, Antos A, Bembenek J and Cz
Onkowska A: Neurological deterioration in Wilson's disease-types,
etiology, course, and management. Discov Med. 36:646–654. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ramli FF, Hashim SAS, Raman B, Mahmod M
and Kamisah Y: Role of Trientine in hypertrophic cardiomyopathy: A
review of mechanistic angles. Pharmaceuticals (Basel). 15:11452022.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Amadi CN, Offor SJ, Frazzoli C and
Orisakwe OE: Natural antidotes and management of metal toxicity.
Environ Sci Pollut Res Int. 26:18032–18052. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Karginova O, Weekley CM, Raoul A, Alsayed
A, Wu T, Lee SS, He C and Olopade OI: Inhibition of copper
transport induces apoptosis in Triple-negative breast cancer cells
and suppresses tumor angiogenesis. Mol Cancer Ther. 18:873–885.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Leitch JM, Jensen LT, Bouldin SD, Outten
CE, Hart PJ and Culotta VC: Activation of Cu, Zn-superoxide
dismutase in the absence of oxygen and the copper chaperone CCS. J
Biol Chem. 284:21863–21871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Yang Y, Feng Q, Luan Y, Liu H, Jiao Y, Hao
H, Yu B, Luan Y and Ren K: Exploring cuproptosis as a mechanism and
potential intervention target in cardiovascular diseases. Front
Pharmacol. 14:12292972023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Hinshaw DC and Shevde LA: The Tumor
microenvironment innately modulates cancer progression. Cancer Res.
79:4557–4566. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Tardito S, Bassanetti I, Bignardi C,
Elviri L, Tegoni M, Mucchino C, Bussolati O, Franchi-Gazzola R and
Marchiò L: Copper binding agents acting as copper ionophores lead
to caspase inhibition and paraptotic cell death in human cancer
cells. J Am Chem Soc. 133:6235–6242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Krasnovskaya O, Naumov A, Guk D, Gorelkin
P, Erofeev A, Beloglazkina E and Majouga A: Copper coordination
compounds as biologically active agents. Int J Mol Sci.
21:39652020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Zheng P, Zhou C, Lu L, Liu B and Ding Y:
Elesclomol: A copper ionophore targeting mitochondrial metabolism
for cancer therapy. J Exp Clin Cancer Res. 41:2712022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Zhang HA and Kitts DD: Turmeric and its
bioactive constituents trigger cell signaling mechanisms that
protect against diabetes and cardiovascular diseases. Mol Cell
Biochem. 476:3785–3814. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Banfi G, Salvagno GL and Lippi G: The role
of ethylenediamine tetraacetic acid (EDTA) as in vitro
anticoagulant for diagnostic purposes. Clin Chem Lab Med.
45:565–576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Alvarez HM, Xue Y, Robinson CD,
Canalizo-Hernández MA, Marvin RG, Kelly RA, Mondragón A,
Penner-Hahn JE and O'Halloran TV: Tetrathiomolybdate inhibits
copper trafficking proteins through metal cluster formation.
Science. 327:331–334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhang S, Liu H, Amarsingh GV, Cheung CC,
Hogl S, Narayanan U, Zhang L, McHarg S, Xu J, Gong D, et al:
Diabetic cardiomyopathy is associated with defective myocellular
copper regulation and both defects are rectified by divalent copper
chelation. Cardiovasc Diabetol. 13:1002014. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Zhang L, Ward ML, Phillips AR, Zhang S,
Kennedy J, Barry B, Cannell MB and Cooper GJ: Protection of the
heart by treatment with a divalent-copper-selective chelator
reveals a novel mechanism underlying cardiomyopathy in diabetic
rats. Cardiovasc Diabetol. 12:1232013. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Lu J, Gong D, Choong SY, Xu H, Chan YK,
Chen X, Fitzpatrick S, Glyn-Jones S, Zhang S, Nakamura T, et al:
Copper(II)-selective chelation improves function and antioxidant
defences in cardiovascular tissues of rats as a model of diabetes:
Comparisons between triethylenetetramine and three less
copper-selective transition-metal-targeted treatments.
Diabetologia. 53:1217–1226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Gong D, Lu J, Chen X, Choong SY, Zhang S,
Chan YK, Glyn-Jones S, Gamble GD, Phillips AR and Cooper GJ:
Molecular changes evoked by triethylenetetramine treatment in the
extracellular matrix of the heart and aorta in diabetic rats. Mol
Pharmacol. 70:2045–2051. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Pan Q, Bao LW and Merajver SD:
Tetrathiomolybdate inhibits angiogenesis and metastasis through
suppression of the NFkappaB signaling cascade. Mol Cancer Res.
1:701–706. 2003.PubMed/NCBI
|
|
150
|
Ouyang P, Gottlieb SH, Culotta VL and
Navas-Acien A: EDTA chelation therapy to reduce cardiovascular
events in persons with diabetes. Curr Cardiol Rep. 17:962015.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Lamas GA, Goertz C, Boineau R, Mark DB,
Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J and Lee KL; TACT
Investigators, : Effect of disodium EDTA chelation regimen on
cardiovascular events in patients with previous myocardial
infarction: The TACT randomized trial. JAMA. 309:1241–1250. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Ujueta F, Arenas IA, Escolar E, Diaz D,
Boineau R, Mark DB, Golden P, Lindblad L, Kim H, Lee KL and Lamas
GA: The effect of EDTA-based chelation on patients with diabetes
and peripheral artery disease in the Trial to Assess Chelation
Therapy (TACT). J Diabetes Complications. 33:490–494. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Jomova K, Makova M, Alomar SY, Alwasel SH,
Nepovimova E, Kuca K, Rhodes CJ and Valko M: Essential metals in
health and disease. Chem Biol Interact. 367:1101732022. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Stiles LI, Ferrao K and Mehta KJ: Role of
zinc in health and disease. Clin Exp Med. 24:382024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Pajarillo EAB, Lee E and Kang DK: Trace
metals and animal health: Interplay of the gut microbiota with
iron, manganese, zinc, and copper. Anim Nutr. 7:750–761. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Qiu Y, Li C, Huang Y, Wu C, Li F, Zhang X
and Xia D: Exploring the causal associations of micronutrients on
Urate levels and the risk of gout: A Mendelian randomization study.
Clin Nutr. 43:1001–1012. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Salehifar E, Shokrzadeh M, Ghaemian A,
Aliakbari S and Saeedi Saravi SS: The study of Cu and Zn serum
levels in idiopathic dilated cardiomyopathy (IDCMP) patients and
its comparison with healthy volunteers. Biol Trace Elem Res.
125:97–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wacewicz M, Socha K, Soroczyńska J,
Niczyporuk M, Aleksiejczuk P, Ostrowska J and Borawska MH:
Concentration of selenium, zinc, copper, Cu/Zn ratio, total
antioxidant status and c-reactive protein in the serum of patients
with psoriasis treated by narrow-band ultraviolet B phototherapy: A
case-control study. J Trace Elem Med Biol. 44:109–114. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ghaemian A, Salehifar E, Jalalian R,
Ghasemi F, Azizi S, Masoumi S, Shiraj H, Mohammadpour RA and
Bagheri GA: Zinc and copper levels in severe heart failure and the
effects of atrial fibrillation on the zinc and copper status. Biol
Trace Elem Res. 143:1239–1246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Luo Z, Yin F, Wang X and Kong L: Progress
in approved drugs from natural product resources. Chin J Nat Med.
22:195–211. 2024.PubMed/NCBI
|
|
161
|
Han Y, Zhu J, Yang L, Nilsson-Payant BE,
Hurtado R, Lacko LA, Sun X, Gade AR, Higgins CA, Sisso WJ, et al:
SARS-CoV-2 infection induces ferroptosis of sinoatrial node
pacemaker cells. Circ Res. 130:963–977. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Del Re DP, Amgalan D, Linkermann A, Liu Q
and Kitsis RN: Fundamental mechanisms of regulated cell death and
implications for heart disease. Physiol Rev. 99:1765–1817. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Corradini E, Buzzetti E and Pietrangelo A:
Genetic iron overload disorders. Mol Angles Med.
75:1008962020.PubMed/NCBI
|
|
165
|
Müller T, Dewitz C, Schmitz J, Schröder
AS, Bräsen JH, Stockwell BR, Murphy JM, Kunzendorf U and Krautwald
S: Necroptosis and ferroptosis are alternative cell death pathways
that operate in acute kidney failure. Cell Mol Life Sci.
74:3631–3645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhao Y, Li Y, Zhang R, Wang F, Wang T and
Jiao Y: The role of Erastin in Ferroptosis and its prospects in
cancer therapy. Onco Targets Ther. 13:5429–5441. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Kunutsor SK, Voutilainen A, Kurl S and
Laukkanen JA: Serum copper-to-zinc ratio is associated with heart
failure and improves risk prediction in middle-aged and older
Caucasian men: A prospective study. Nutr Metab Cardiovasc Dis.
32:1924–1935. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Wang D, Tian Z, Zhang P, Zhen L, Meng Q,
Sun B, Xu X, Jia T and Li S: The molecular mechanisms of
cuproptosis and its relevance to cardiovascular disease. Biomed
Pharmacother. 163:1148302023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Majewski M, Ognik K and Juśkiewicz J:
Copper nanoparticles enhance vascular contraction induced by
prostaglandin F2-alpha and decrease the blood plasma cu-zn ratio in
wistar rats. J Elem. 24:911–922. 2019.
|
|
170
|
Tousson E and El-Gharbawy DM: Impact of
Saussurea lappa root extract against copper oxide nanoparticles
induced oxidative stress and toxicity in rat cardiac tissues.
Environ Toxicol. 38:415–421. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Huo S, Wang Q, Shi W, Peng L, Jiang Y, Zhu
M, Guo J, Peng D, Wang M, Men L, et al: ATF3/SPI1/SLC31A1 signaling
promotes cuproptosis induced by advanced glycosylation end products
in diabetic myocardial injury. Int J Mol Sci. 24:16672023.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Piavchenko G, Alekseev A, Stelmashchuk O,
Seryogina E, Zherebtsov E, Kuznetsova E, Dunaev A, Volkov Y and
Kuznetsov S: A complex morphofunctional approach for zinc toxicity
evaluation in rats. Heliyon. 6:e037682020. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Karagulova G, Yue Y, Moreyra A, Boutjdir M
and Korichneva I: Protective role of intracellular zinc in
myocardial ischemia/reperfusion is associated with preservation of
protein kinase C isoforms. J Pharmacol Exp Ther. 321:517–525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Yang HJ, Kong B, Shuai W, Zhang JJ and
Huang H: Shensong Yangxin attenuates metabolic syndrome-induced
atrial fibrillation via inhibition of ferroportin-mediated
intracellular iron overload. Phytomedicine. 101:1540862022.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Fang J, Kong B, Shuai W, Xiao Z, Dai C,
Qin T, Gong Y, Zhu J, Liu Q and Huang H: Ferroportin-mediated
ferroptosis involved in new-onset atrial fibrillation with
LPS-induced endotoxemia. Eur J Pharmacol. 913:1746222021.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Kitala K, Tanski D, Godlewski J,
Krajewska-Włodarczyk M, Gromadziński L and Majewski M: Copper and
zinc particles as regulators of cardiovascular system function-a
review. Nutrients. 15:30402023. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Jomova K, Vondrakova D, Lawson M and Valko
M: Metals, oxidative stress and neurodegenerative disorders. Mol
Cell Biochem. 345:91–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Li JW, Mao YM, Chen SL, Ye R, Fei YR, Li
Y, Tong SY, Yang HW and He YB: The interplay between metal ions and
immune cells in glioma: Pathways to immune escape. Discov Oncol.
15:3482024. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Yuan S, Chen S, Xi Z and Liu Y:
Copper-finger protein of Sp1: The molecular basis of copper
sensing. Metallomics. 9:1169–1175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Su TA, Bruemmer KJ and Chang CJ: Caged
luciferins for bioluminescent activity-based sensing. Curr Opin
Biotechnol. 60:198–204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Guo B, Yang F, Zhang L, Zhao Q, Wang W,
Yin L, Chen D, Wang M, Han S, Xiao H and Xing N: Cuproptosis
induced by ROS responsive nanoparticles with elesclomol and copper
combined with αPD-L1 for enhanced cancer immunotherapy. Adv Mater.
35:e22122672023. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Liu S, Zhao Y, Shen M, Hao Y, Wu X, Yao Y,
Li Y and Yang Q: Hyaluronic acid targeted and pH-responsive
multifunctional nanoparticles for chemo-photothermal synergistic
therapy of atherosclerosis. J Mater Chem B. 10:562–570. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Li Y, Yang J, Zhang Q, Xu S, Sun W, Ge S,
Xu X, Jager MJ, Jia R, Zhang J and Fan X: Copper ionophore
elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
Oncogene. 41:3539–3553. 2022. View Article : Google Scholar : PubMed/NCBI
|
